Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression
Authors:
- 16 October 2024
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 263, 155652
Abstract
No abstract availableKeywords
This publication has 218 references indexed in Scilit:
- Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem CellsAdvanced Science, 2024
- Cellular senescence in cancer: molecular mechanisms and therapeutic targetsMedcomm, 2024
- Cell fate regulation governed by p53: Friends or reversible foes in cancer therapyCancer Communications, 2024
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- Cellular senescence and the tumour microenvironmentMolecular Oncology, 2022
- Targeting cellular senescence to combat cancer and ageingMolecular Oncology, 2022
- Cellular senescence in cancer: from mechanisms to detectionMolecular Oncology, 2020
- Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA‐424 in osteosarcomaJournal of Clinical Laboratory Analysis, 2019
- Tetramer formation of tumor suppressor protein p53: Structure, function, and applicationsPeptide Science, 2016
- Arecoline‐induced phosphorylated p53 and p21WAF1 protein expression is dependent on ATM/ATR and phosphatidylinositol‐3‐kinase in clone‐9 cellsJournal of Cellular Biochemistry, 2009